PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
24.02%
Net income growth at 50-75% of CRWD's 32.34%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.
-24.51%
Negative yoy D&A while CRWD is 16.89%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
92.25%
Some yoy growth while CRWD is negative at -396.65%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
7.93%
SBC growth while CRWD is negative at -2.98%. John Neff would see competitor possibly controlling share issuance more tightly.
-47.87%
Negative yoy working capital usage while CRWD is 36.31%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
194.53%
AR growth well above CRWD's 206.25%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-221.91%
Both reduce yoy inventory, with CRWD at -77.31%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-89.59%
Negative yoy AP while CRWD is 150.45%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-172.94%
Both reduce yoy usage, with CRWD at -40.69%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-62.03%
Negative yoy while CRWD is 43.77%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
3.55%
Operating cash flow growth below 50% of CRWD's 49.12%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-3.44%
Negative yoy CapEx while CRWD is 24.98%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
70.85%
Some acquisitions while CRWD is negative at -9.56%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
22.77%
Less growth in investment purchases vs. CRWD's 85.68%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
-24.36%
We reduce yoy sales while CRWD is 1913.19%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-67.85%
We reduce yoy other investing while CRWD is 9.56%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-20.37%
We reduce yoy invests while CRWD stands at 210.94%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
60.29%
We slightly raise equity while CRWD is negative at -100.00%. John Neff sees competitor possibly preserving share count or buying back shares.
-16.44%
Both yoy lines negative, with CRWD at -100.00%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.